Executive Venture Partner@ Novo Ventures
San Francisco Bay Area
Natalie Sacks
GET FULL PROFILE 
University of Pennsylvania School of Medicine
Real-Time AI Research
FlashIntel GPT
Tell me more about Natalie Sacks?
FlashIntel GPTNatalie Sacks is a highly experienced drug developer and biopharma executive with over 21 years of work experience. She has held various leadership positions in renowned companies such as Novo Ventures, Harpoon Therapeutics, Caribou Biosciences, Zymeworks Inc., Aduro Biotech Is Now Chinook Therapeutics, and Xerox. Natalie has a strong background in general management and has worked with renowned companies like Novo Ventures, Harpoon Therapeutics, and Caribou Biosciences. She is currently an independent board director at Novo Ventures. Natalie's expertise lies in the pharmaceutical industry, specifically in areas such as biopharma, biopharma, and biotechnology research.
For inquiries about Phone Number and Email, please click here Unlock Contact
Emails and Phone Numbers
About
Drug Developer - Biopharma Executive - Independent Board Director
Work Experience
Executive Venture Partner
Venture Partner
Biotechnology Research
Natalie Sacks's Professional Milestones
- Chief Medical Officer (2018-01-01~2022-01-01): Transforming Transformed the company's reputation through strategic partnerships and effective leadership.
- Member Board Of Directors (2018-01-01~): Boosted organizational growth and developed an innovative governance strategy.
Education
Certification
Colleagues
Other Named Natalie Sacks
Frequently asked questions
We found 4 Natalie Sacks's email addresses
We found 2 Natalie Sacks's phone numbers
Natalie Sacks's social media include: Linkedin,
Natalie Sacks works for Novo Ventures
Natalie Sacks's role in Novo Ventures is Executive Venture Partner
Natalie Sacks works in the industry of Biotechnology Research
Natalie Sacks's colleagues are Susan Chen,Timothy Zhou
Natalie Sacks's latest job experience is Executive Venture Partner at Novo Ventures
Natalie Sacks's latest education in University of Pennsylvania School of Medicine
